Cornerstone Advisors (Washington)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-5,325
| Closed | -$328K | – | 1019 |
|
|
2019
Q2 | $328K | Buy |
5,325
+147
| +3% | +$9.06K | 0.03% | 89 |
|
|
2019
Q1 | $330K | Buy |
5,178
+2,577
| +99% | +$164K | 0.03% | 82 |
|
|
2018
Q4 | $133K | Buy |
2,601
+123
| +5% | +$6.29K | 0.02% | 160 |
|
|
2018
Q3 | $144K | Buy |
2,478
+363
| +17% | +$21.1K | 0.09% | 161 |
|
|
2018
Q2 | $103K | Buy |
2,115
+111
| +6% | +$5.41K | 0.07% | 193 |
|
|
2018
Q1 | $93K | Hold |
2,004
| – | – | 0.06% | 201 |
|
|
2017
Q4 | $75K | Sell |
2,004
-576
| -22% | -$21.6K | 0.05% | 221 |
|
|
2017
Q3 | $94K | Sell |
2,580
-696
| -21% | -$25.4K | 0.06% | 195 |
|
|
2017
Q2 | $129K | Buy |
3,276
+657
| +25% | +$25.9K | 0.07% | 153 |
|
|
2017
Q1 | $82K | Hold |
2,619
| – | – | 0.04% | 205 |
|
|
2016
Q4 | $82K | Sell |
2,619
-606
| -19% | -$19K | 0.07% | 197 |
|
|
2016
Q3 | $130K | Buy |
3,225
+723
| +29% | +$29.1K | 0.11% | 133 |
|
|
2016
Q2 | $83K | Sell |
2,502
-6
| -0.2% | -$199 | 0.08% | 119 |
|
|
2016
Q1 | $74K | Buy |
2,508
+162
| +7% | +$4.78K | 0.08% | 132 |
|
|
2015
Q4 | $62K | Buy |
2,346
+2,190
| +1,404% | +$57.9K | 0.07% | 154 |
|
|
2015
Q3 | $4K | Hold |
156
| – | – | ﹤0.01% | 581 |
|
|
2015
Q2 | $4K | Hold |
156
| – | – | ﹤0.01% | 440 |
|
|
2015
Q1 | $4K | Hold |
156
| – | – | ﹤0.01% | 460 |
|
|
2014
Q4 | $3K | Hold |
156
| – | – | ﹤0.01% | 489 |
|
|
2014
Q3 | $3K | Sell |
156
-24
| -13% | -$462 | ﹤0.01% | 329 |
|
|
2014
Q2 | $3K | Hold |
180
| – | – | ﹤0.01% | 364 |
|
|
2014
Q1 | $2K | Buy |
180
+24
| +15% | +$267 | ﹤0.01% | 367 |
|
|
2013
Q4 | $2K | Hold |
156
| – | – | ﹤0.01% | 236 |
|
|
2013
Q3 | $2K | Hold |
156
| – | – | ﹤0.01% | 217 |
|
|
2013
Q2 | $2K | Buy |
+156
| New | +$2K | ﹤0.01% | 180 |
|